SPN0103-009

N/A

Report date: 2023/02/21 17:44:44
NME

Base Information

Drug NameSPN0103-009
Drug Alias NameGLP-1肽类似物（澳赛诺生物）SPN0103-009SPN-0103-009SPN-009SPN010 +[6] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAllsino Chemicals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAllsino Chemicals Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A